Loading company…
Mitor Pharmaceuticals researches oncology therapies, including small molecule drug candidates.
Mitor Pharmaceuticals researches and develops oncology therapies intended to address unmet medical needs. Its work includes ClpP small molecule agonist pipelines and early-stage oncology and immunomodulatory drug discovery. Founded in 2024 and based in Chengdu, China, it received Seed funding from Chengdu Science and Technology Venture Capital Group in April 2026 to support preclinical development, IND-enabling studies, and an R&D platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in